本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

擁抱未來控股有限公司

0.023
+0.0014.55%
成交量:5.24萬
成交額:1,202.90
市值:3,986.92萬
市盈率:-12.53
高:0.023
開:0.023
低:0.022
收:0.022
52周最高:0.033
52周最低:0.008
股本:17.33億
流通股本:5.59億
量比:0.06
換手率:0.01%
股息:- -
股息率:- -
每股收益(TTM):-0.002
每股收益(LYR):-0.003
淨資產收益率:-1275.15%
總資產收益率:-62.22%
市淨率:35.85
市盈率(LYR):-6.57

資料載入中...

公司資料

公司名字:
擁抱未來控股有限公司
交易所:
SGX
成立時間:
2009
員工人數:
7
公司地址:
18 Howard Road,No.11-09 Novelty BizCentre,Singapore,Singapore
郵編:
369585
電話:
傳真:
- -
簡介:
Biolidics Limited is a Singapore-based precision medicine medical technology company. The Company's principal activities are technology development, technology transfer, marketing, selling and distribution of biomedical technology, life and medicine science related products and services; provision of laboratory services; and investment holding. It has three segments: cancer diagnostics, infectious diseases and laboratory services. Cancer diagnostics segment develops and commercializes the ClearCell FX1 System, a fully automated CE-IVD medical device, which separate and enrich cancer cells from blood, allows users of the system to perform liquid biopsies. Infectious diseases segment develops, markets and/or distributes certified test kits with various diagnostic partners. Laboratory services segment offers a range of tests. The laboratory has a regulatory approval from Singapore’s Ministry of Health for molecular microbiology testing and PCR testing services for COVID-19 in Singapore.